Page last updated: 2024-10-29

indomethacin and Mesothelioma

indomethacin has been researched along with Mesothelioma in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Mesothelioma: A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manning, LS1
Bowman, RV1
Davis, MR1
Musk, AW1
Robinson, BW1

Other Studies

1 other study available for indomethacin and Mesothelioma

ArticleYear
Indomethacin augments lymphokine-activated killer cell generation by patients with malignant mesothelioma.
    Clinical immunology and immunopathology, 1989, Volume: 53, Issue:1

    Topics: Asbestos; Cytotoxicity, Immunologic; Drug Synergism; Environmental Exposure; Humans; Indomethacin; I

1989